Preoperative Oral Carbohydrate on Gastric Emptying

February 28, 2024 updated by: Emine Şeyda Teloğlu, Bezmialem Vakif University

The Effect of A Newly Formulated Preoperative Oral Carbohydrate Solution on Gastric Emptying, Postoperative Nausea and Vomiting and Stress Response

The current preoperative fasting guidelines recommend, applying preoperative carbohydrate solution 2 hours before the operation to minimize prolonged fasting time potential negative effects and improve patient comfort. Fasting after midnight before the operation day is a widespread practice. The major obstacle to preoperative carbohydrate solutions becoming prevalent and extremely long fasting time is the limited product; which is proven safe and efficient, and unavailable in several countries. In this study, our objective is to analyze the gastric volume, preoperative anxiety, stress response, postoperative insulin resistance, and postoperative nausea and vomiting by utilizing a low osmolality oral carbohydrate solution prepared with ginger and melissa.

Study Overview

Status

Recruiting

Detailed Description

The current preoperative fasting guidelines recommend, applying preoperative carbohydrate solution 2 hours before the operation to minimize prolonged fasting time potential negative effects and improve patient comfort. Fasting after midnight before the operation day is a widespread practice. The major obstacle to preoperative carbohydrate solutions becoming prevalent and extremely long fasting time is the limited product; which is proven safe and efficient, and unavailable in several countries. In this study, our objective is to analyze the gastric volume, preoperative anxiety, stress response, postoperative insulin resistance, and postoperative nausea and vomiting by utilizing a low osmolality oral carbohydrate solution prepared with ginger and melissa.

109 patients who underwent elective laparoscopic cholecystectomy, aged 18-65 years, and ASA physical state 1-2 were included in the study. The patients were divided into 3 groups: Group A, who would not eat anything 6-8 hours before the operation, Group S, who drank 400 ml of water 2 hours before the operation, and Group K, which drank 400 ml preoperative oral carbohydrate solution (PreOKH) 2 hours before the operation. Before induction of anesthesia (T1), patients' antral gastric cross-sectional area (GKA) and gastric volume (GV) were evaluated by gastric ultrasound. The preoperative anxiety level of the patients was determined by the State-Trait Anxiety Inventory (STAl) before the operation (T1), and the symptoms affecting the preoperative patient comfort parameters (thirst, hunger, dry mouth, fatigue) were measured 2 hours before the operation (T0) and before the induction (T1) evaluated with the visual analog scale (VAS). Postoperative nausea and vomiting (PONV) and postoperative pain levels were recorded. Blood glucose, insulin, and cortisol levels of the patients were measured 2 hours before the operation (T0), before induction (T1), and postoperative 2nd hour (T3)

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Fatih
      • Istanbul, Fatih, Turkey
        • Recruiting
        • Bezmialem University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Between the ages of 18-65
  • Elective laparoscopic cholecystectomy planned under general anesthesia
  • American Society of Anesthesiologists (ASA) class I-II physical condition

Exclusion Criteria:

Patients with gastroesophageal reflux and gastrointestinal motility disorders diabetes mellitus Mental retardation, previous neurological disease symptoms (syncope, dementia, Alzheimer, etc.) Chronic alcoholism Difficult Intubation Patients with ASA physical status classes ≥III Patients with a body mass index of 35 and above History of Meniere and motion sickness Presence of previous history of postoperative nausea and vomiting Smoking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Starvation
Fasting for 6-8 hours before the operation
Active Comparator: Water
drink 400ml of water 2 hours before the operation
water and solution will be given to patients to drink 2 hours before the operation
Other Names:
  • Water
Active Comparator: oral carbohydrate
drink 400ml of solution 2 hours before the operation
water and solution will be given to patients to drink 2 hours before the operation
Other Names:
  • Water

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastric volume
Time Frame: prior to anesthesia induction
Assessment of gastric volume by ultrasound
prior to anesthesia induction

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
preoperative anxiety
Time Frame: before coming to the operating room, Scored between 20 and 80 points. A high score indicates high anxiety
preoperative anxiety will be assessed with the State-Trait Anxiety Inventory
before coming to the operating room, Scored between 20 and 80 points. A high score indicates high anxiety
postoperative nausea and vomiting
Time Frame: up to postoperative 24 hours, numeric rank score is scored between 0 and 3 points
postoperative nausea and vomiting scores of the patients will be evaluated
up to postoperative 24 hours, numeric rank score is scored between 0 and 3 points
thirst, hunger, fatigue, dry mouth
Time Frame: before drink (2 hous before surgery), prior to anesthesia induction, visual analog scale is scored between 0 and 10
thirst, hunger, fatigue, dry mouth will be evaluated with visual analog scale
before drink (2 hous before surgery), prior to anesthesia induction, visual analog scale is scored between 0 and 10
Postoperative Pain Score
Time Frame: up to postoperative 24 hours, visual analog scale is scored between 0 and 10
Postoperative Pain Score will be evaluated with visual analog scale
up to postoperative 24 hours, visual analog scale is scored between 0 and 10
postoperative insulin resistance
Time Frame: glucose, insulin and cortisol will be measured 2 hours before surgery(before drink), before induction and 2 hours postoperatively
Blood glucose mg/dL, Insulin milli-International unit/L, Cortisol µg/dL
glucose, insulin and cortisol will be measured 2 hours before surgery(before drink), before induction and 2 hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Estimated)

April 1, 2024

Study Completion (Estimated)

April 15, 2024

Study Registration Dates

First Submitted

January 29, 2024

First Submitted That Met QC Criteria

February 28, 2024

First Posted (Estimated)

March 4, 2024

Study Record Updates

Last Update Posted (Estimated)

March 4, 2024

Last Update Submitted That Met QC Criteria

February 28, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • BVU-ESTELOGLU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe